Immunic reported $189.74M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
BioMarin Pharmaceutical USD 11.72B 3.13B Jun/2026
Cipla INR 424.96B 23.32B Mar/2026
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 145.86M 10.71M Mar/2026
CSL USD 37.9B 1.5B Dec/2025
Enanta Pharmaceuticals USD 329.5M 48.77M Dec/2025
Grifols EUR 23.15B 142.7M Dec/2025
Immunic USD 189.74M 165.69M Mar/2026
Insmed USD 2.1B 26.7M Jun/2026
Omeros USD 200.57M 34.59M Jun/2025
OraSure Technologies USD 360.55M 18.62M Jun/2026
Quidel USD 5.72B 86.6M Jun/2026
Ultragenyx Pharmaceutical USD 1.26B 32M Jun/2026
United Therapeutics USD 7.22B 505.9M Jun/2026